Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01748942 · ClinicalTrials.gov registry record · NA

Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer

A NA study, sponsored by OHSU Knight Cancer Institute.

Completed
Registry status
NA
Development phase
76
Enrollment target

NCT01748942: Completed NA study, sponsored by OHSU Knight Cancer Institute.

NCT01748942 is a NA study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01748942, a NA study, has completed, sponsored by OHSU Knight Cancer Institute.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target

Study Summary

This randomized pilot clinical trial studies dexamethasone in reducing oral pain and dry mouth after surgery in patients with oropharyngeal cancer. Dexamethasone may help lower pain and dry mouth caused by surgery.

Primary Outcome

Visual Analog Scale (VAS) is a 0-10 scale for patients to indicate intensity level of pain with 0 indicating "No pain" and 10 indicating "Worst possible, unbearable, excruciating pain". A descriptive time plot of VAS scores will be produced for all enrolled subjects, with loess curve fitted separately for the experimental and control groups. A linear mixed effects model will be used to compare the pain VAS scores between the experimental and control groups.

Interventions

  • OTHER Placebo
  • OTHER Questionnaire Administration
  • DRUG Dexamethasone
  • PROCEDURE Quality-of-Life Assessment

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2012-12
Est. Completion 2017-03-29
Phase NA
OHSU Knight Cancer Institute

211 total trials

What the finished NCT01748942 record still lists

NCT01748942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT01748942 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01748942 about?

NCT01748942 is a clinical study titled "Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer". This randomized pilot clinical trial studies dexamethasone in reducing oral pain and dry mouth after surgery in patients with oropharyngeal cancer. Dexamethasone may help lower pain and dry mouth caused by surgery.

What is the current status of trial NCT01748942?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2012-12. Estimated completion is 2017-03-29.

What interventions are being tested in trial NCT01748942?

The interventions under investigation include: Placebo (OTHER), Questionnaire Administration (OTHER), Dexamethasone (DRUG), Quality-of-Life Assessment (PROCEDURE).

Who is sponsoring clinical trial NCT01748942?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01748942's enrollment target sits among peer trials

76 1062nd of 2000 higher than 932 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01748942, the US trial registry maintained by the National Library of Medicine. NCT01748942 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.